1 Sep 2026
Citation Bureau
Vol. I
No. 300
Reference

What is glp 1?

glp 1

GLP-1 drugs are a class of medications originally developed for diabetes that have become widely used for weight loss. As of mid-2026, they are described as “brain drugs and fat loss drugs” rather than cosmetic weight loss aids, with effects extending to reducing alcohol, smoking, and gambling urges. The main thread in current discussion is the significant gap between the drugs’ popularity and the lack of comprehensive support for users, leading to high discontinuation rates and concerns about muscle loss and weight regain.

How it developed

  • Jun 2026 - Christopher Gardner said that 20 to 40% of weight lost on GLP-1 drugs can be lean mass, and that lack of physical exercise is usually the driver of that lean mass loss.
  • Jun 2026 - Christopher Gardner noted that over 90% of people who access these drugs do so outside a complete support system, and cited a UK patient who developed scurvy due to inadequate nutrition while on the drugs.
  • Jun 2026 - Christopher Gardner said that about 50 to 60% of people stop taking the drug within a year because they can’t tolerate side effects, and that those who stop will regain weight mostly as fat.
  • Jun 2026 - Christopher Gardner emphasized that protein intake is pointless without resistance training, and that some patients stopped the drug because they stopped enjoying their lives.
  • Aug 2026 - Daniel Lieberman cited a recent paper estimating that about 60% of people on these drugs quit them after about a year.

In the evidence

Every line below is attributed to a named speaker.

By the numbers

20 to 40 percent of weight lost on GLP-1 drugs can come from lean mass, including muscle and bone.

“We know that 20 to 40% of weight lost can be from lean mass, your muscle and your bones.”
Christopher Gardner · 18 Jun 2026
Contrarian take

A UK patient on GLP-1 drugs without dietary support developed scurvy, illustrating that suppressed appetite without nutritional guidance can cause severe micronutrient deficiency.

“There was a patient in the UK who had scurvy. So, bleeding gums, people couldn't understand what was going on. he'd been taking these drugs without any support and just hadn't been eating fruits and vegetables, basically.”
Christopher Gardner · 18 Jun 2026
By the numbers

About 50 to 60 percent of GLP-1 drug users stop within a year due to intolerable side effects, with some estimates reaching two-thirds.

“About 50 to 60% of people stop taking the drug within a year because they can't tolerate the side effects.”
Christopher Gardner · 18 Jun 2026
Best explained

Cycling on and off GLP-1 drugs without diet and lifestyle changes is particularly harmful because weight regained after stopping comes back predominantly as fat, worsening body composition over time.

“If you then come off the drugs, you will regain the weight lost mostly as fat.”
Christopher Gardner · 18 Jun 2026
By the numbers

Over 90 percent of GLP-1 drug users access the medication outside of a complete clinical support system.

“Over 90% of people who access these drugs do so outside of a complete support system.”
Christopher Gardner · 18 Jun 2026
Best explained

Lean mass loss on GLP-1 drugs is driven primarily by physical inactivity, not low protein intake, making resistance exercise the critical intervention.

“It's usually a lack of physical exercise that's driving their lean mass loss.”
Christopher Gardner · 18 Jun 2026
By the numbers

Approximately 60% of people prescribed GLP-1 drugs discontinue them within about one year, per a recent paper cited by Daniel Lieberman.

“The last paper I read on this just a few days ago estimated that over that about 60% of people on these on these on these drugs do quit them after about a year.”
Daniel Lieberman · 6 Aug 2026
Worth quoting

Christopher Gardner reframes GLP-1 drugs as neurological and metabolic tools, not cosmetic aids.

“They're really brain drugs and fat loss drugs. Like, they're not cosmetic weight loss drugs.”
Christopher Gardner · 18 Jun 2026
Contrarian take

GLP-1 drug side effects can include anhedonia so severe that some patients voluntarily stop treatment because they lose enjoyment of life entirely.

“For some patients I've worked with, that stopped them taking the drug because they stopped enjoying their lives.”
Christopher Gardner · 18 Jun 2026
Worth quoting

Christopher Gardner on the futility of high protein intake without resistance training while on GLP-1 drugs.

“Can I just be super clear again here that protein intake is pretty pointless unless you're doing this resistance training.”
Christopher Gardner · 18 Jun 2026
Citation Bureau · reference note, compiled from attributed expert discussion. Last updated 2026-08-21.